Strategic Reimbursement Planning: Aligning Value Across Stakeholders for Commercial Success

Effective reimbursement strategy for your innovation is not only about securing codes, coverage, and payment, it’s about aligning your product’s value proposition with the needs of all key stakeholders across the healthcare ecosystem. Our approach to strategic reimbursement planning and execution is predictive, integrated, and tailored to your innovation. It's the cornerstone of a successful commercialization strategy.

We develop comprehensive, forward-looking reimbursement strategies that anticipate market dynamics, address payer expectations, and equip providers with the tools they need to adopt your technology. By articulating clinical, economic, and patient-centered value, we help you establish a compelling case for access and support successful product commercialization.

We support you across the entire reimbursement lifecycle, from early planning through post-market execution. Whether you're engaging with payers, providers, health systems, or policymakers, we position your product for long-term market acceptance and growth.

Market Intelligence

PRIA partners with MedTech innovators early, delivering strategic market intelligence that informs product planning, de-risks commercialization, and aligns innovation with payer, provider, and patient needs.

• Market Assessments
• Strategic Product Planning
• Competitive Landscape Analysis
• Pricing Strategy

Coding Strategy & Development

PRIA helps you navigate the evolving coding landscape and ensure your innovation is accurately and optimally represented.

• New code applications (CPT, ICD-10-PCS, HCPCS), including garnering society support and CPT pull through
• Coding gap analyses
• Procedure-to-technology mapping
• Provider and internal team education

Payer Coverage Strategy & Evidence Development

Coverage is earned through clarity, credibility, and trusted advisory relationships. We build strategies that align your clinical evidence with payer expectations.

• Payer coverage landscape assessments and proactive payer coverage surveillance 
• Clinical evidence mapping and health economic support
• Payer value dossiers and clinical compendium development
• Evidence strategy development and tool creation: Real-world evidence generation, study protocol development, and health economics and outcomes research
  

Payment Strategy & Modeling

PRIA’s strategic experts’ model financial impact and optimize payment pathways to support sustainable access and provider adoption.

• Payment benchmarking (Government and commercial)
• NTAP and TPT support for new technology payments
• Inpatient and outpatient reimbursement strategy
• Retrospective claims analytics to support payment strategy
  
  

Commercial Readiness Tools

PRIA equips your teams with practical resources that bridge the gap between strategy and execution.

• Payment benchmarking (Government and commercial)
• DRG/APC impact analyses
• NTAP and TPT support and education with facilities to pull through alternative payment methods
• Health Economics and Outcomes Research (HEOR): facility proformas, budget impact models
  
  

Market Access Strategy: Powering MedTech Innovation Through Proven Access Pathways

At PRIA Healthcare, we believe that a great product alone isn’t enough, true success in MedTech comes from ensuring your innovation reaches the patients and providers who need it most. That’s why market access is at the heart of everything we do.

We build and execute comprehensive market access strategies that accelerate adoption, overcome access barriers, and position your technology for long-term growth. By aligning clinical, economic, and real-world value with the priorities of payers, providers, and policymakers, we help you transform innovation into impact.

Access Strategy Development

We craft tailored, end-to-end market access roadmaps designed to support your commercialization goals - whether you're preparing for launch or scaling post-market.

• Payment benchmarking (Government and commercial)
• DRG/APC impact analyses
• NTAP and TPT support for new technology payments
• Inpatient and outpatient reimbursement strategy
  
  

Health Economics & Value Messaging

Demonstrating the economic and clinical value of your technology is essential. We help translate your data into persuasive, actionable narratives for decision-makers.

• Cost-effectiveness modeling
• Budget impact analyses
• Value proposition frameworks for different stakeholders
• Payer communication strategy
  
  

Evidence Alignment for Access

We guide you in generating the right data, clinical, economic, and experiential, to support coding, coverage, and
payment success.

• Evidence strategy that supports payer needs
• Real-world evidence and outcomes planning
• Alignment with reimbursement and policy objectives
  
  

Access Enablement Tools

We provide tactical assets and training that empower your team to activate your market access strategy in the field.

• Field team training on payer messaging and policy navigation
• Patient access resources and support tools
• Billing and coding education for provider partners
• And so much more
  
  

Reimbursement Hotline Services: Expert Support When It Matters Most

PRIA’s Hotline Services provide your team, providers, and patients with real-time access to reimbursement and market access expertise. We ensure the swift resolution of questions and challenges that arise throughout the commercialization journey.

Our knowledgeable specialists offer personalized guidance on coding, coverage, payment, and access issues, helping to reduce delays, streamline workflows, and improve satisfaction across all stakeholders.

Key Features:

On-Demand Reimbursement & Access Support

• Immediate answers to complex coding, billing, and payer inquiries
• Dedicated help navigating authorization, appeals, and benefit verification
  
  

Proactive Provider Assistance

• New Account Support to streamline adoption, collaborating with your field team to answer questions before they arise.
  
  

Issue Tracking & Reporting

• Detailed analytics to identify common barriers and inform strategy refinement
  
  

Flexible Integration

• Seamless coordination with your field teams, call centers, and patient support programs
  
  

Reliable Expertise, Anytime You Need It

• With PRIA’s Hotline Services, you empower your network with the knowledge and support to overcome access challenges, accelerating adoption and driving commercial success.

Payer & Stakeholder Engagement: Strategic Influence That Unlocks Access and Drives Adoption

In today’s rapidly evolving healthcare environment, securing reimbursement and widespread adoption demands more than strong clinical data, it requires a deliberate, insight-driven engagement strategy with the right stakeholders at the right time. From national and regional payers to providers, health systems, and policy influencers, PRIA helps you build trusted relationships that move the dial on coverage and accelerate market penetration.

We understand that payer engagement is not transactional - it’s transformational. And it starts well before product launch. Our approach is grounded in the belief that clinical development, evidence strategy, and market access planning must be tightly aligned from the outset to anticipate payer expectations and reduce barriers to adoption.

With deep knowledge of payer decision-making, evolving policy dynamics, and unmet information needs, PRIA empowers MedTech innovators to enter the market with confidence—and impact.

(Step One) Strategic Diligence: Laying the Groundwork for Informed, High-Impact Engagement

Effective engagement begins with intelligence. We lead a rigorous discovery process to map your landscape, identify key access drivers, and develop a strategic framework that ensures your outreach is credible, timely, and tailored to the payer mindset.

Key Activities:

Stakeholder Mapping & Influence Strategy

Identify and prioritize payer, provider, and policy decision-makers based on clinical indication, site of care, and geographic relevance

Coverage Policy & Evidence Requirements Assessment

Analyze existing payer coverage, precedent policies, and clinical expectations to reveal gaps, risks, and opportunities

Clinical & Economic Value Alignment

Ensure your clinical development plan, endpoints, and outcomes align with payer expectations and value frameworks
—starting early

Messaging & Positioning Strategy

Develop evidence-based, payer-facing value narratives that resonate across cost, quality, and outcomes metrics

Engagement Roadmap Development

Create a phased, multi-stakeholder outreach plan to build credibility, address objections, and maintain momentum

(Step Two) Execution & Advocacy: Engaging Payers with Precision and Purpose

Armed with insights, PRIA leads the charge in executing your engagement strategy—translating data into dialogue and dialogue into access. Our experts act as strategic guides and tactical executors, ensuring every interaction builds trust and advances your commercialization goals.

Key Activities:

Payer Meeting Preparation & Facilitation

Lead or support meetings with targeted materials, tailored messaging, and clear objectives that showcase your
technology’s value

Advisory Board Development & Moderation

Organize and facilitate payer, provider, or multi-stakeholder advisory boards to gather feedback, validate assumptions, and build advocacy

Ongoing Stakeholder Communication

Establish and manage communication cadences with decision-makers to sustain engagement and respond to evolving needs

Medical Society & Advocacy Alignment

Engage key influencers to support coding efforts, shape policy, and reinforce the clinical legitimacy of your technology

Feedback Loops to Strategy

Translate insights from the field into actionable refinements for your evidence plan, value messaging, and broader
access strategy

A Changing Market Demands a Smarter Strategy

The reimbursement landscape is shifting. Value-based care, prior authorization pressures, and increasingly sophisticated payer evaluation processes have raised the bar for market entry. At PRIA, we don’t just keep up - we stay ahead.

Our team brings decades of experience working alongside commercial and government payers, and we understand what it takes to influence decisions. We know the questions they’ll ask,and we help you answer them before they’re even raised.

The Time is Now. Engage Early, Align Strategically and Execute with Confidence.

With PRIA as your partner, you’re not just entering the market, you’re shaping how the market receives you.

Regulatory Strategy & Marketing Submissions: Aligning Pathway, Evidence, and Claims for Commercial Success

An effective regulatory strategy is not only about obtaining clearance, approval, or authorization; it’s about building a pathway that supports the product you want to commercialize. The decisions made early around device classification, indications for use, claims, evidence generation, and submission strategy can directly shape market access, payer coverage, investor confidence, and long-term commercial success.

PRIA’s approach to regulatory strategy is practical, predictive, and commercially aligned. We help MedTech innovators understand what is required, what is strategically useful, and what may create unnecessary cost or delay. By integrating regulatory planning with reimbursement, clinical, and market access considerations, we help companies avoid costly rework and build evidence packages that support both FDA expectations and downstream adoption.



We support clients across the regulatory lifecycle, from early product planning and pathway assessment through FDA engagement, marketing submissions, global expansion, and post-market regulatory strategy. Whether you are preparing for a 510(k), De Novo, PMA, IDE, Breakthrough Device designation, or global market entry, PRIA helps position your product for efficient authorization and meaningful commercial impact.

Key Features:

Regulatory Pathway & Classification Strategy

PRIA helps MedTech innovators define the appropriate regulatory pathway and understand how early product decisions influence development timelines, evidence needs, and commercialization opportunities.

• Device classification and product code assessments
• 510(k), De Novo, PMA, IDE, and enforcement discretion pathway evaluations
• Intended use, indications for use, and claims strategy
• Predicate and substantial equivalence strategy
• Regulatory roadmap development for staged product launches and future indication expansion 

FDA Engagement & Expedited Program Strategy

PRIA helps companies engage FDA with clear, focused questions and practical strategies that support faster decision-making, reduced uncertainty, and stronger development planning.

• FDA Pre-Submissions and Q-Submissions
• Breakthrough Device designation strategy and submissions
• TAP and early payer alignment strategy for eligible technologies
• FDA meeting preparation, briefing materials, and response strategy
• Sprint discussion planning and targeted FDA interaction support 

Marketing Applications & Submission Execution

PRIA supports the development, preparation, and execution of regulatory submissions that are complete, defensible, and aligned with the product’s commercial objectives.

• 510(k) Premarket Notifications
• De Novo Classification Requests
• Premarket Approval (PMA) strategy and support
• IDE strategy and Investigational Device Exemption submissions
• Submission gap assessments, content development, and FDA response support 

Evidence, Testing & Clinical Strategy

PRIA helps companies develop evidence strategies that support regulatory authorization while also considering provider adoption, payer expectations, and long-term commercialization needs.

• Bench, performance, and verification testing strategy
• Biocompatibility, usability, electrical safety, software, and cybersecurity strategy
• Clinical evidence planning and study design support
• Labeling, claims, and evidence alignment
• Testing strategy designed to reduce unnecessary duplication and support future product changes 

Global Regulatory Strategy

PRIA supports companies pursuing international expansion by helping align global regulatory requirements with U.S. strategy, evidence generation, and commercial priorities.

• EU MDR and IVDR regulatory strategy
• EU Technical Documentation planning and gap assessments
• Notified Body engagement support
• UKCA and APAC pathway planning, including PMDA and MFDS considerations
• Global submission sequencing and market entry strategy

Quality Systems: Building Scalable Compliance for MedTech Growth

A quality system should do more than satisfy regulatory requirements. It should support product development, manufacturing, commercialization, and long-term growth. For MedTech innovators, the right quality system is not the biggest or most complex one, it is the one that fits the company’s product, risk profile, stage of development, and operational reality.

PRIA helps companies build, implement, and improve quality systems that are practical, compliant, and scalable. Our approach is focused on right-sizing quality infrastructure so companies can meet FDA QMSR, ISO 13485, MDSAP, and other applicable requirements without creating unnecessary burden or procedures the organization cannot sustain.

We support companies from early QMS development through commercialization, inspection readiness, remediation, and quality system scaling. Whether you are building your first QMS, preparing for a submission, implementing an eQMS, responding to FDA observations, or supporting diligence for investment or acquisition, PRIA helps ensure your quality system is built to support the business, not slow it down.

QMS Development & Implementation



PRIA helps MedTech companies establish quality management systems that are compliant, practical, and appropriate for the company’s size, stage, and product complexity.

• FDA QMSR and ISO 13485-aligned QMS development 

• MDR/IVDR and MDSAP ready Quality manual, SOP, work instruction, and form development 

• eQMS selection, implementation, and process configuration 

• Quality system gap assessments and implementation roadmaps 

• Scalable quality infrastructure for early-stage and growth-stage companies 

Design Controls & Risk Management

PRIA supports product development teams in building design control and risk management processes that support regulatory submissions, product development, and long-term lifecycle management.

• Design control process development and implementation
• Design History File (DHF) structure and remediation
• Risk management planning and ISO 14971 implementation
• Requirements traceability and design verification planning
• Usability engineering and human factors process integration 

QMS Development & Implementation



PRIA helps MedTech companies establish quality management systems that are compliant, practical, and appropriate for the company’s size, stage, and product complexity.

• FDA QMSR and ISO 13485-aligned QMS development 

• MDR/IVDR and MDSAP ready Quality manual, SOP, work instruction, and form development 

• eQMS selection, implementation, and process configuration 

• Quality system gap assessments and implementation roadmaps 

• Scalable quality infrastructure for early-stage and growth-stage companies 

Quality Remediation, Audit & Due Diligence

PRIA helps companies identify quality system gaps, remediate compliance issues, and prepare for inspections, investment, or acquisition.

• Internal audits and quality system gap assessments
• FDA inspection readiness and mock audits
• 483 and warning letter remediation support
• Quality system remediation and recovery planning
• Regulatory and quality due diligence for investors, acquirers, and strategic partners